BridgeBio Pharma, Inc 10-Q for FY2025 Q2
BridgeBio Pharma, Inc. (BBIO)
10-Q
2025-08-05
For: 2025-06-30
View Original
Added on
April 08, 2026
About this 10-Q
BridgeBio Pharma, Inc filed this 10-Q on August 5, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).
Headline figures
Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $110.57M
- up 4999.9% from $2.17M a year earlier
- Net loss
- $183.76M
- compared with a net loss of $75.54M a year earlier
- Diluted EPS
- -$0.95
- compared with -$0.39 a year earlier